Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1968 May;52(5):396–399. doi: 10.1136/bjo.52.5.396

Treatment of active toxoplasmic retino-choroiditis.

J Nolan, E S Rosen
PMCID: PMC506606  PMID: 5301644

Full text

PDF
396

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BEVERLEY J. K. A rational approach to the treatment of toxoplasmic uveitis. Trans Opthal Soc U K. 1958;78:109–121. [PubMed] [Google Scholar]
  2. BOGACZ J. Action comparée sur les toxoplasmes de diverses substances synthétiques et de quelques antibiotiques dont la spiramycine. Bull Soc Pathol Exot Filiales. 1954;47(6):903–915. [PubMed] [Google Scholar]
  3. CANAMUCIO C. J., HALLETT J. W., LEOPOLD I. H. Recurrence of treated toxoplasmic uveitis. Am J Ophthalmol. 1963 May;55:1035–1039. [PubMed] [Google Scholar]
  4. FAJARDO R. V., FURGIUELE F. P., LEOPOLD I. H. Treatment of toxoplasmosis uveitis. Arch Ophthalmol. 1962 Jun;67:712–720. doi: 10.1001/archopht.1962.00960020712004. [DOI] [PubMed] [Google Scholar]
  5. GARIN J. P., EYLES D. E. Le traitement de la toxoplasmose expérimentale de la souris par la spiramycine. Presse Med. 1958 May 28;66(42):957–958. [PubMed] [Google Scholar]
  6. GHOSH M., LEVY P. M., LEOPOLD I. H. THERAPY OF TOXOPLASMOSIS UVEITIS. Am J Ophthalmol. 1965 Jan;59:55–61. doi: 10.1016/0002-9394(65)95020-8. [DOI] [PubMed] [Google Scholar]
  7. GILES C. L., JACOBS L., MELTON M. L. CHEMOTHERAPY OF EXPERIMENTAL TOXOPLASMOSIS. EVALUATIONOF SPIRAMYCIN ALONE AND IN COMBINATION. Arch Ophthalmol. 1964 Jan;71:119–127. doi: 10.1001/archopht.1964.00970010135021. [DOI] [PubMed] [Google Scholar]
  8. KAUFMAN H. E., REMINGTON J., MELTON M. L., JACOB S. L. Relative resistance of slow-growing strains of Toxoplasma gondii to pyrimethamine (daraprim). Arch Ophthalmol. 1959 Oct;62:611–615. doi: 10.1001/archopht.1959.04220040073010. [DOI] [PubMed] [Google Scholar]
  9. KAUFMAN H. E. The penetration of daraprim (pyrimethamine) into the monkey eye. Am J Ophthalmol. 1961 Sep;52:402–404. doi: 10.1016/0002-9394(61)90741-3. [DOI] [PubMed] [Google Scholar]
  10. TENPAS A., ABRAHAM J. P. HEMATOLOGICAL SIDE-EFFECTS OF PYRIMETHAMINE IN THE TREATMENT OF OCULAR TOXOPLASMOSIS. Am J Med Sci. 1965 Apr;249:448–453. doi: 10.1097/00000441-196504000-00014. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES